Bay Colony Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bay Colony Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5	Closed	–	–	604
2018 Q2	$0	Buy	+5	New	+$178	﹤0.01%	956

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bay Colony Advisors's LMAT Position: Q3 2018 in Review

Bay Colony Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2018, closing a stake of 5 shares.

Bay Colony Advisors first reported a position in LMAT in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 156 funds tracked by Wall St. Rank hold LMAT as of Q3 2018.

Bay Colony Advisors reported no remaining LeMaitre Vascular position as of Q3 2018 after selling out during the quarter.
Bay Colony Advisors sold 5 LeMaitre Vascular shares in Q3 2018.
Bay Colony Advisors first reported a position in LeMaitre Vascular in Q2 2018 and held it in 1 quarter.
Bay Colony Advisors's LeMaitre Vascular position peaked at $0 in Q2 2018.
156 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2018.

Based on Bay Colony Advisors's 13F filing for Q3 2018, filed 5 Nov 2018.